Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market to Witness Astonishing Growth by 2029

The global NASH biomarkers market is anticipated to grow significantly at a CAGR of 28.6% during the forecast period. The growing number of hepatitis with obesity and other chronic liver disease is growing the global Non-alcoholic Steatohepatitis Biomarkers market. Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents leading to a range of health problems. Factors such as hepatitis and obesity have contributed to the diagnosis and treatment market, as the number of patients increases the need for these Non-alcoholic Steatohepatitis Biomarkers increases. According to WHO, 354 million peoples across the globe live with hepatitis B or C.

  • Globally, an estimated 58 million people have chronic hepatitis C virus infection, with about 1.5 million new infections occurring per year.
  • WHO estimated that in 2019, approximately 290 000 people died from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma (primary liver cancer).

According to a WHO study around 4.5 million premature deaths could be prohibited in low- and middle-income countries by 2030 through vaccination, diagnostic tests, medicines, and education campaigns, which further contribute to the growth of the global Non-alcoholic Steatohepatitis Biomarkers market. In addition, Obesity and chronic liver disease patients fuelling the market. For instance according to CDC, in the US  the number of adults with diagnosed liver disease is around 4.5 million with 51,642 deaths. Hence diagnosis and treatment are vastly needed which is increasing the market.

To Request a Sample of our Report on Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market:  https://www.omrglobal.com/request-sample/non-alcoholic-steatohepatitis-biomarkers-market

Market Coverage

  • The market number available for – 2022-2030
  • Base year- 2022
  • Forecast period- 2023-2030

Segment Covered-

  • By Biomarker Type
  • By End-Users

Regions Covered-

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
  • Competitive Landscape- Allergan PLC, Bristol-Myers Squibb Co., Gilead Sciences, Inc., Siemens Healthcare Medical Solutions Ltd., and Thermo Fisher Scientific, Inc., among others.

Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market Segmentation

By Biomarker Type

  • Serum Biomarkers
  • Hepatic Fibrosis Biomarkers
  • Apoptosis Biomarkers
  • Oxidative Stress Biomarkers
  • Others (Carbon Isotope Markers and miRNA Biomarkers)

By End-Users 

  • Hospitals
  • Diagnostic Laboratories
  • Academic Research Institute
  • Pharmaceutical Companies/CRO

A full Report of Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market is Available @  https://www.omrglobal.com/industry-reports/non-alcoholic-steatohepatitis-biomarkers-market

 Non-Alcoholic Steatohepatitis (NASH) Biomarkers Market by Region 

North America                                                                                                           

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia-Pacific

  • India
  • China
  • Japan
  • South Korea
  • Rest of APAC

Rest of the World

  • Latin America
  • Middle East and Africa

Company Profiles 

  • Allergan PLC
  • ALPCO
  • Antaros Medical AB
  • BioPredictive S.A.S
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Co.
  • Covance Inc.
  • Enterome SA
  • GENFIT SA
  • Gilead Sciences, Inc.
  • Laboratory Corporation of America Holdings
  • NGM Biopharmaceuticals, Inc.
  • Nordic Bioscience
  • OWL Metabolomics
  • Perspectum Diagnostics Ltd
  • Prometheus Laboratories Inc.
  • ProSciento
  • Quest Diagnostics Inc.
  • Siemens Healthcare Medical Solutions Ltd.
  • Thermo Fisher Scientific, Inc.
  • Xeptagen SpA

Reasons to buy from us –

  1. We cover more than 15 major industries, further segmented into more than 90 sectors.
  2. More than 120 countries are for analysis.
  3. Over 100+ paid data sources mined for investigation.
  4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-alcoholic-steatohepatitis-biomarkers-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404